Abstract
This week marks the launch of the new AAAS journal Science Translational Medicine . I am very pleased that we were able to recruit Elias A. Zerhouni, the distinguished former director of the U.S. National Institutes of Health, to be its chief scientific adviser, and Katrina L. Kelner, until recently the Deputy Editor for Biological Sciences at Science , to be its editor. As Zerhouni writes in his editorial, the goals of this journal, and of translational medicine more broadly, are to speed the rate at which the astounding recent advances in our basic understanding of biological mechanisms are exploited for preventing and treating human disease. *
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
